EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Price, Forecast & Analysis
Europe - BIT:1EW - US28176E1082 - Common Stock
1EW.MI Key Statistics, Chart & Performance
The current stock price of 1EW.MI is 66.48 EUR.
1EW.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 16.59 | 101.95B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.19 | 48.83B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.87 | 23.39B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.82 | 23.32B | ||
| BIM.PA | BIOMERIEUX | 27.62 | 12.62B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.83 | 3.80B | ||
| DIA.MI | DIASORIN SPA | 17.07 | 3.31B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.42 | 1.26B | ||
| DRW8.DE | DRAEGERWERK AG | 9.05 | 1.10B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.54 | 994.72M | ||
| ELN.MI | EL.EN. SPA | 17 | 872.90M | ||
| GVS.MI | GVS SPA | 46.5 | 791.72M |
Related stock screener links
About 1EW.MI
Company Profile
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 19,800 full-time employees. The company went IPO on 2000-03-27. The firm is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). The company develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.
Company Info
EDWARDS LIFESCIENCES CORP
One Edwards Way
Irvine CALIFORNIA US
Employees: 19800
Phone: 19492502500
EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ
Can you describe the business of EDWARDS LIFESCIENCES CORP?
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. The company is headquartered in Irvine, California and currently employs 19,800 full-time employees. The company went IPO on 2000-03-27. The firm is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). The company develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.
What is the current price of 1EW stock?
The current stock price of 1EW.MI is 66.48 EUR. The price decreased by -8.14% in the last trading session.
Does EDWARDS LIFESCIENCES CORP pay dividends?
1EW.MI does not pay a dividend.
How is the ChartMill rating for EDWARDS LIFESCIENCES CORP?
1EW.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Where is EDWARDS LIFESCIENCES CORP (1EW.MI) stock traded?
1EW.MI stock is listed on the Euronext Milan exchange.
Can you provide the market cap for EDWARDS LIFESCIENCES CORP?
EDWARDS LIFESCIENCES CORP (1EW.MI) has a market capitalization of 39.08B EUR. This makes 1EW.MI a Large Cap stock.
1EW.MI Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to 1EW.MI.
1EW.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI. Both the health and profitability get an excellent rating, making 1EW.MI a very profitable company, without any liquidiy or solvency issues.
1EW.MI Financial Highlights
Over the last trailing twelve months 1EW.MI reported a non-GAAP Earnings per Share(EPS) of 2.41. The EPS increased by 4.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 76.28% | ||
| ROA | 31.98% | ||
| ROE | 41.75% | ||
| Debt/Equity | 0.06 |
1EW.MI Forecast & Estimates
41 analysts have analysed 1EW.MI and the average price target is 77.45 EUR. This implies a price increase of 16.51% is expected in the next year compared to the current price of 66.48.
For the next year, analysts expect an EPS growth of -3.61% and a revenue growth 0.84% for 1EW.MI